Another limitation is the lack of data on the evolution of BMI during the follow-up period, which could affect the interpretation of our results
Mechanistically, these effects reflect a combination of central and peripheral actions: Moiz et al
Noom also partners with Castlight Health to distribute its programs Noom Weight, Noom Med, Noom Diabetes, and Noom Diabetes Prevention to employers and health plans via Castlight's platform, which the company claims can drive a 3.25x increase in engagement
This is the central tension of training on a GLP-1 drug, and managing it well is the difference between losing fat while preserving muscle and losing both
(Serena did not disclose which specific medication she is on
Second, regulators and major ad platforms are tightening rules fast